Catalysts for $IGC
651 tracked
Dec 22, 2025
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
PROBUPHINE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
FIORICET W/ CODEINE (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
BELBUCA (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→